Penn Radiology’s Basic Research Division includes laboratories focused on basic imaging methodology. Our research labs are separated into quantitative, biomedical imaging informatics, and molecular imaging labs.

  • Biomedical Imaging Informatics

    Studies of the science of information related to medical imaging, including image analysis and the integration of data from medical imaging into scientific research and clinical practice.

  • AIBIL

    The Artificial Intelligence in Biomedical Imaging Lab (AIBIL) focuses on machine learning in neuroimaging, including imaging signatures of brain aging, Alzheimer’s Disease, schizophrenia, and brain cancer, as well as of functional connectivity.

  • CBICA

    The Center for Biomedical Image Computing and Analytics (CBICA) was established in 2013, and focuses on the development and application of advanced computational and analytical techniques that quantify morphology and function from biomedical images.

  • Center for Global and Population Health Research

    Center for Global and Population Health Research

  • Computational Biomarker Imaging Group (CBIG)

    Our goal is to act as a translational catalyst between the worlds of computation imaging science and clinical breast cancer research. Learn more here.

  • DiCIPHR Lab

    The Diffusion & Connectomics In Precision Healthcare Research (DiCIPHR) Lab aims to develop subject-specific imaging biomarkers paving the way for precision imaging.

  • Medical Image Processing Group (MIPG)

    The Medical Image Processing Group (MIPG) conducts full-time medically relevant research in imaging science and offers training to students and post-doctoral fellows.

  • Penn Image Computing and Science Lab (PICSL)

    Research at The Penn Image Computing and Science Laboratory (PICSL) spans numerous collaborations across a variety of disciplines and includes targeted applications of biomedical image analysis to improve the detection of subtle changes on imaging studies.

  • Molecular Imaging and Image-Guided Therapy

    Studies of imaging designed for the visualization, characterization, and measurement of biological processes at the molecular and cellular levels as well as therapy guided by either anatomic imaging, molecular imaging, or both.

  • Breast Cancer Molecular Imaging Group

    The Breast Cancer Molecular Imaging Group at Penn Medicine seeks better methods for breast cancer treatment. The lab is supported by a grant from the Susan G. Komen Foundation.

  • Breast Cancer Translational Research Group (BCTRG)

    The Breast Cancer Translational Research Group (BCTRG) bench to bedside research program aims to understand differences in cancer DNA repair mechanisms and develop predictive biomarkers for targeted therapy response.

  • Britton Chance Laboratory of Redox Imaging

    The lab employs a combination of metabolic imaging and spectroscopy and biological methods to probe the role of NAD(H) redox status in diseases and develop metabolic/redox biomarkers for clinical translation.

  • Delikatny Translational Molecular Imaging Lab

    The Delikatny Lab focuses on imaging methods for the detection of tumors in lung and breast cancer.

  • Functional and Metabolic Imaging Group (FMIG)

    The goal of the Functional and Metabolic Imaging Group (FMIG) is the development and application of novel hyperpolarized MRI techniques capable of diagnosing a variety of pulmonary and metabolic disorders.

  • Laboratory of Molecular Imaging (LMI)

    The overall goal of the Laboratory of Molecular Imaging is to foster synergistic and symbiotic collaborations between tumor biologists and the imaging community.

  • Metabolic & Molecular Imaging of Cardiovascular Diseases (MMICD) Lab

    The Metabolic and Molecular Imaging of Cardiovascular Diseases (MMICD) Lab develops experimental and therapeutic approaches to treat heart failure and cancer.

  • Molecular and Cellular Technologies Lab (MCTL)

    The Molecular and Cellular Technologies Lab at Penn Medicine uses a combination of synthetic chemistry, as well as chemical and synthetic biology to address both basic and translational challenges in imaging and therapy.

  • Nanomedicine and Molecular Imaging Lab (NAMIL)

    Research at the Nanomedicine and Molecular Imaging Lab (NAMIL) focuses on the development of novel and multifunctional nanoparticle contrast agents for medical imaging applications.

  • Penn Image-Guided Interventions Laboratory (PIGI)

    The Penn Image-Guided Interventions (PIGI) Laboratory is dedicated to the translational investigation of a multitude of topics of interest to interventional radiology as well as the broader medical community.

  • Radiopharmaceutical Chemistry and Biology Lab

    The Radiopharmaceutical Chemistry and Biology Lab is dedicated to interdisciplinary research across the Radiology Department at Penn Medicine.

  • Radiopharmaceutical Chemistry Section

    The Radiopharmaceutical Chemistry Section focuses on the development of new radiopharmaceuticals that provide diagnostic information on various organs in normal and disease states.

  • Radiopharmaceutical Therapy and Companion Diagnostics Group

    The Radiopharmaceutical Therapy and Companion Diagnostics Group, under the direction of Daniel A. Pryma, MD, operates in close collaboration with the Radiopharmaceutical Chemistry and Biology Lab.

Share This Page: